Narcolepsy type 1 and type 2 study in Spain
Part of Brain & nervous system clinical trials.
This study looks at people with narcolepsy type 1 or type 2 in Spain to learn more about these conditions. If you or your child has a confirmed diagnosis, you may be able to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with narcolepsy type 1 or type 2 by a sleep specialist.
- You are alive at any time during 2023 or 2024.
- You live in Spain and are treated or followed at a participating hospital in the study.
- You are any age, gender, ethnicity, or nationality.
- If you are under 18, a parent or guardian can participate on your behalf.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares gut bacteria and substances from the gut in people with type 1 narcolepsy versus those without. It aims to understand how gut health might be linked to this sleep disorder.
This study tests whether a new medication called ALKS 2680 can help people with narcolepsy type 1 stay more awake and alert during the day. Narcolepsy type 1 is a neurological condition where people fall asleep unexpectedly and may experience sudden muscle weakness.
This study tests an investigational drug called ALKS 2680 for people with narcolepsy type 2, a condition that causes excessive daytime sleepiness without sudden muscle weakness. The goal is to see if the drug is safe and helps reduce daytime sleepiness.
This study tests a new medication, ALKS 2680, to see if it helps reduce daytime sleepiness and other symptoms in adults with narcolepsy type 1. It may offer a new treatment option for people with this condition.
This study tests whether a new medication called cleminorexton helps people with narcolepsy (a condition causing severe daytime sleepiness) sleep better and feel more alert. You would take this medication instead of your current narcolepsy drugs for several months to see if it works.
This study tests a new medicine called TAK-360 for people with narcolepsy type 2 (narcolepsy without cataplexy). It aims to see if the drug safely reduces daytime sleepiness.
Hear when a new Narcolepsy Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.